Hardy Reed’s Bristol-Myers Squibb BMY Stock Holding History

Hardy Reed’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$501K	Buy	8,689 +343	+4%	+$19.7K	0.03%	153
2026 Q1	$506K	Buy	8,346 +269	+3%	+$15.7K	0.04%	141
2025 Q4	$436K	Buy	8,077 +263	+3%	+$12.7K	0.03%	153
2025 Q3	$352K	Buy	7,814 +1,125	+17%	+$52.5K	0.03%	179
2025 Q2	$310K	Buy	6,689 +61	+0.9%	+$2.99K	0.02%	181
2025 Q1	$404K	Buy	6,628 +123	+2%	+$7.17K	0.04%	149
2024 Q4	$368K	Buy	6,505 +70	+1%	+$3.91K	0.03%	161
2024 Q3	$333K	Buy	6,435 +105	+2%	+$4.93K	0.03%	173
2024 Q2	$263K	Buy	+6,330	New	+$283K	0.03%	200

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hardy Reed's BMY Position: Q2 2026 in Review

Hardy Reed increased its Bristol-Myers Squibb (BMY) stake by 4.1% in Q2 2026, buying an estimated $19.7K and bringing the position to 8,689 shares worth $501K. The position accounts for 0.03% of the portfolio, ranked #153.

Hardy Reed first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $506K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hardy Reed held 8,689 shares of Bristol-Myers Squibb worth $501K as of Q2 2026.
Hardy Reed bought 343 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.7K.
Bristol-Myers Squibb made up 0.03% of Hardy Reed's portfolio in Q2 2026, its #153 holding.
Hardy Reed first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
Hardy Reed's Bristol-Myers Squibb position peaked at $506K in Q1 2026.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.